Disease response
Response . | VAD, no. (%); N = 219 . | ASCT no. 1, no. (%); n = 182 . | ASCT no. 2 Arm A, no. (%); n = 85 . | ASCT no. 2 Arm B, no. (%); n = 81 . | P . |
|---|---|---|---|---|---|
| CR | 9 (4.1) | 26 (14.3) | 26 (30.6) | 28 (34.6) | .62 |
| VGPR | 26 (11.9) | 36 (19.8) | 16 (18.8) | 14 (17.3) | .84 |
| PR | 104 (47.5) | 98 (53.8) | 39 (45.9) | 31 (36.5) | .44 |
| Stable or MR | 49 (22.3) | 16 (8.8) | 2 (2.4) | 4 (4.9) | .43 |
| Progressive | 25 (11.4) | 4 (2.2) | 1 (1.2) | 2 (2.5) | .61 |
| Death | 6 (2.7) | 2 (1.1) | 1 (1.2) | 2 (2.5) | .61 |
Response . | VAD, no. (%); N = 219 . | ASCT no. 1, no. (%); n = 182 . | ASCT no. 2 Arm A, no. (%); n = 85 . | ASCT no. 2 Arm B, no. (%); n = 81 . | P . |
|---|---|---|---|---|---|
| CR | 9 (4.1) | 26 (14.3) | 26 (30.6) | 28 (34.6) | .62 |
| VGPR | 26 (11.9) | 36 (19.8) | 16 (18.8) | 14 (17.3) | .84 |
| PR | 104 (47.5) | 98 (53.8) | 39 (45.9) | 31 (36.5) | .44 |
| Stable or MR | 49 (22.3) | 16 (8.8) | 2 (2.4) | 4 (4.9) | .43 |
| Progressive | 25 (11.4) | 4 (2.2) | 1 (1.2) | 2 (2.5) | .61 |
| Death | 6 (2.7) | 2 (1.1) | 1 (1.2) | 2 (2.5) | .61 |
CR indicates complete response; VGPR, very good partial response; PR, partial response; MR minimal response.